These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33537791)

  • 1. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD.
    Moosvi Z; Duong JT; Bechtold ML; Nguyen DL
    South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative outcomes in vedolizumab-treated pediatric patients undergoing abdominal operations for inflammatory bowel disease.
    Lightner AL; Tse CS; Potter DD; Moir C
    J Pediatr Surg; 2018 Sep; 53(9):1706-1709. PubMed ID: 29111083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease.
    Lightner AL; Raffals LE; Mathis KL; Cima RR; Tse CS; Pemberton JH; Dozois EJ; Loftus EV
    J Crohns Colitis; 2017 Feb; 11(2):185-190. PubMed ID: 27543504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease.
    Law CCY; Narula A; Lightner AL; McKenna NP; Colombel JF; Narula N
    J Crohns Colitis; 2018 Apr; 12(5):538-545. PubMed ID: 29718245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease.
    Law CC; Bell C; Koh D; Bao Y; Jairath V; Narula N
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013256. PubMed ID: 33098570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
    Yamada A; Komaki Y; Patel N; Komaki F; Aelvoet AS; Tran AL; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
    Am J Gastroenterol; 2017 Sep; 112(9):1423-1429. PubMed ID: 28719595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients.
    Moosvi Z; Duong J; Bechtold ML; Nguyen DL
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):799-816. PubMed ID: 33079779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between vedolizumab and postoperative complications in IBD: a systematic review and meta-analysis.
    Guo D; Jiang K; Hong J; Zhang M; Shi Y; Zhou B
    Int J Colorectal Dis; 2021 Oct; 36(10):2081-2092. PubMed ID: 34467414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?
    Lightner AL; McKenna NP; Alsughayer A; Harmsen WS; Taparra K; Parker ME; Raffals LE; Loftus EV
    Dis Colon Rectum; 2019 Nov; 62(11):1352-1362. PubMed ID: 31567927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Lightner AL; Mathis KL; Tse CS; Pemberton JH; Shen B; Kochhar G; Singh A; Dulai PS; Eisenstein S; Sandborn WJ; Parry L; Stringfield S; Hudesman D; Remzi F; Loftus EV
    Inflamm Bowel Dis; 2018 Mar; 24(4):871-876. PubMed ID: 29509927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease.
    Yung DE; Horesh N; Lightner AL; Ben-Horin S; Eliakim R; Koulaouzidis A; Kopylov U
    Inflamm Bowel Dis; 2018 Oct; 24(11):2327-2338. PubMed ID: 29788385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
    Lightner AL; McKenna NP; Tse CS; Raffals LE; Loftus EV; Mathis KL
    Aliment Pharmacol Ther; 2018 Mar; 47(5):573-580. PubMed ID: 29250800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY.
    Krugliak Cleveland N; Ghosh S; Chastek B; Bancroft T; Candela N; Fan T; Umashankar K; Rubin DT
    BMC Gastroenterol; 2024 Sep; 24(1):314. PubMed ID: 39289603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-matched Comparison of Postoperative Outcomes Following Surgery for Inflammatory Bowel Disease After Exposure to Vedolizumab vs Other Biologics.
    Novello M; Stocchi L; Steele SR; Holubar SD; Duraes LC; Kessler H; Shawki S; Hull LT
    J Crohns Colitis; 2020 Feb; 14(2):185-191. PubMed ID: 31328222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study.
    Kim JY; Zaghiyan K; Lightner A; Fleshner P
    BMC Surg; 2020 Mar; 20(1):46. PubMed ID: 32138717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases.
    Singh S; Iversen AT; Allin KH; Jess T
    JAMA Netw Open; 2022 Sep; 5(9):e2234200. PubMed ID: 36178685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy.
    Ferrante M; de Buck van Overstraeten A; Schils N; Moens A; Van Assche G; Wolthuis A; Vermeire S; D'Hoore A
    J Crohns Colitis; 2017 Oct; 11(11):1353-1361. PubMed ID: 28981886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab.
    Zimmerman LA; Zalieckas JM; Shamberger RC; Bousvaros A
    J Pediatr Surg; 2018 Jul; 53(7):1330-1333. PubMed ID: 29370898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
    Lightner AL; McKenna NP; Alsughayer A; Loftus EV; Raffals LE; Faubion WA; Moir C
    J Pediatr Surg; 2019 Oct; 54(10):2162-2165. PubMed ID: 30773391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.